MediaWE ARE BUILDING THE FUTURE OF EDUCATION

07/03/2022

МНОГО Е УДОВЛЕТВОРЯВАЩО, КОГАТО „ЧИСТАТА” НАУКА НАВЛЕЗЕ В ПРАКТИКАТА

Проф. Николай Желев е световноизвестен учен, признат за гений, заради създаването на изкуствено човешко сърце с диаметър едва 1 мм. Проф. Желев е един от впечатляващите примери как учените правят бизнес, за да реализират научната си работа. Той е професор по медицински биотехнологии в Медицинското училище към университета в град Дънди, Обединеното кралство. Почетен професор в осем университета в Обединеното кралство, Китай, България и Русия. Бил е първият Почетен консул на България в Шотландия. Основал е няколко биофармацевтични и биотехнологични компании за разработването на нови лекарства срещу рак и сърдечна хипертрофия.

Read More

07/03/2022

Кристина Ескенази: Биотехнологичният сектор е един от най-бързо развиващите се двигатели на медицината на бъдещето

България има потенциал да създаде 100 нови технолотични стартъпи до 2030 г., убедена е Кристина Ескенази, председател на Биотехнологичен и Здравен Клъстер, член на УС на Клъстер Изкуствен Интелект България, БРАИТ и Българско Бионаучно Общество. Тя е и директор бизнес развитие в Рейдиоактив Ltd., ментор и водещ на редица събития за предприемачество и стартъп култура (Pitch2Pitch, EIT Climate KIC), Национално контактно лице по Хоризонт Европа в клъстер Здраве, член на редица европейски и международни мрежи (EuropaBio, CEBR, European AI Forum, DIH.net, EchAllience и др.). В рамките на настоящата година Кристина пое позицията на Директор Женско предприемачество в първото по рода си за региона Venture Build Studio–VenRize, както и създател на международна асоциация по женско предприемачество в сферата на биотехнологиите “Global Digital Technologies Health Network”

Read More

02/11/2021

The BBI Cambridge and the Vernize Academy sign a partnership agreement to co-promote executive education, professional talent development and the international networking of the life sciences sector across the south-eastern European biocluster.

28/10/2021

The BBI Cambridge and the Vernize Academy sign a partnership agreement to co-promote executive education, professional talent development and the international networking of the life sciences sector across the south-eastern European biocluster.

Cambridge - October 2021, the Venrize Academy and BBI Cambridge have formed an exclusive partnership to promote the world’s first International online eMBA in Life Sciences across south-eastern Europe: Bulgaria, Romania, Serbia, Montenegro, North Macedonia, Albania, Kosovo, Bosna, Slovenia, Croatia, Greece and Turkey.

One of the main objectives of the BBI Business School is to expand its international network development by developing new regional alliances with new bioclusters to expand the community of commercially focused scientific leaders. BBI Cambridge has a unique knowledge of innovation, management and business, when applied to the main commercial opportunities in Life Sciences, such as pharmaceuticals, biotechnology, medical technologies and digital health, as well as other applications.

This is the first collaborative agreement to promote International executive education in Life Sciences and Biotechnology in the south-eastern European region, which includes Bulgaria, Romania, Serbia, Montenegro, North Macedonia, Albania, Kosovo, Bosna, Slovenia, Croatia, Greece and Turkey. This new agreement reinforces the opportunities for developing companies from across the region internationally. We are excited by this partnership with a like-minded educational provider, which promotes a global outlook, entrepreneurship, and the application of science, with an important ambition of addressing patient needs.

The Life Sciences sector is one of the leading and fastest-growing sectors of the Bulgarian economy. From its founding, Health & Life Sciences Cluster Bulgaria supports the development of professional competencies, especially internationalisation, innovation and foresight. We need business leaders working at the intersection of science and society, with a deep understanding of biotechnology, life sciences, and management.

For our ecosystem is a great opportunity to welcome and support in our region the World's first international MBA in Life Sciences and Biotechnology. By joining forces of Venrize Academy and The BBI Cambridge we can ensure well-trained leaders of life sciences, providing them with business skills, scientific critical thinking." - Kristina Eskenazi, Chair of the Health & Life Sciences Cluster Bulgaria.

The scope of our collaboration includes the active development of future business leadership. The BBI Business School has a pedigree in enabling IP creation and company spinouts. We are particularly excited to be working together on accelerating innovative technologies internationally, through venture building and technology transfer opportunities.

The combined programme offers practical experiences across its campuses in Cambridge and Barcelona for students to work on drug discovery and development projects by immersing our students in technology transfer, venture building and international business development. The programme brings together a bustling community of scientists, entrepreneurs, business leaders, corporate partners and investors with the focus on shaping the future of life sciences.

“We are extremely pleased and excited to announce the Biotechnology Business Institute in Cambridge is launching in January 2022. We have established this international academic institution to focus on delivering bespoke executive education specifically aimed at business-focused life scientists.

With the aim to accelerate their overall career development within the wider Life Sciences sectors. We will offer professional and practical development programmes based on the rapidly evolving Life Sciences arenas. Our aim is to help deliver the next generation of outstanding Life science entrepreneurs and business leaders. We are very excited for the future.” – Chris Howie, BBI UK Managing Director.

This collaboration is the first step towards providing a connection between the major European innovation hubs and developing an increase in business transactions, as well as closer international interactions and the global promotion of regional talent.

'We live in unprecedented times of unmet medical needs and the development of life sciences innovation at scale is needed more than ever. By building the next generation of innovators and business leaders, the Biotechnology Business Institute (The BBI) contributes significantly to the tackling of global healthcare challenges. I am delighted to hear that the BBI has chosen to expand its reach to Bulgaria and the Southeast European regions. I believe that by bringing the entrepreneurial spirit of Cambridge, Europe's most advanced biotechnology cluster, the programme will ignite interest in the sector and produce innovation which will save many human lives.' - Martin Shiderov, Head of Health and Life Sciences, Investment Services at EY

THE VENRIZE ACADEMY

Learn more here about the International eMBA in Life Sciences:

INTERNATIONAL ONLINE EMBA IN LIFE SCIENCES

View Press Release:

BBI - Venrize Academy Partnership Agreement

About Venrize Academy

Venrize Academy is an online education provider with the mission to bring the most innovative and impactful education to students and professionals across Southeast Europe (Bulgaria, Romania, Serbia, Montenegro, North Macedonia, Albania, Kosovo, Bosna, Slovenia, Croatia, Greece and Turkey).Our vision is to offer an educational ecosystem which provides continues academic and professional development.

A student’s degree should not be a close-ended process but a catalyst which helps each individual to evolve and achieve career and personal aspiration. This is the reason why, by joining Venrize Academy and our partner programmes, you join a platform which supports you to gain knowledge, accelerate your career, build business, grow your network and expand your global horizons.

About Bulgaria Heath & Life Sciences Cluster ecosystem

Our global community connects 78 countries and 4.4 billion people (Africa, Americas, Asia, Canada, Caribbean, China, Europe, India, the Pacific & USA). Our community of over 20,000 experts – including government, health & social care providers, leading companies and start-ups, researchers, insurances, patients’ groups and citizens, and the investment community connect through ecosystem meetings (120 per year) and international events and our online platform. Our Working Groups provide a platform for stakeholders, responsible for a given topic area, to meet, promote and advance their work across the ecosystem network, therefore maximising knowledge sharing and best practice.

About the BBI Business School Cambridge

Our Cambridge Campus is located in the historic City of Cambridge, with a long tradition of generating academic knowledge at the Bradfield centre at the Cambridge Science Park. The City's entrepreneurial roots have attracted global pharmaceutical companies and many start-ups.

This campus elevates the status of the business school as a reference centre for management internationally and the expansion has allowed the BBI Business to meet a wide range of educational needs for scientists during their career development.

About the BBI Busines School

The Biotechnology Business Institute is an international business school focused on training scientific managers and executives for their future careers.

The BBI facilitates early-stage business development activities amongst key stakeholders from the biotechnology sector and the pharmaceutical industry worldwide. A core focus is on new drug discovery and development to treat unmet medical need.

For more information, visit www.bbi-int.com, follow us on Linked In and www.bbi-int.comSubscribe to our newsletter.

Barcelona Campus

Barcelona Scientific ParkBaldiri Reixac St., 4-8,
08028, Barcelona
info@bbibarcelona.com

Cambridge Campus

The Bradfield Centre, Cambridge Science Park184,
Milton Road, Cambridge, CB4 0GA
info@bbicambridge.com

Media Contact

For any inquiry regarding conferences or media requirements, please contact us at communications@bbibarcelona.com

Disclaimer

The BBI is providing this information based on the current circumstances, as of the date of this press release. The BBI is not under any obligation to update any forward-looking statements contained in this document, resulting from new information, future events or otherwise. Readers should be aware that circumstances may change but this press release is based on the current expectations and beliefs of the BBI. All statements, other than statements of historical fact, are statements that could be deemed forward-looking, including any statements on the outcome, benefits and synergies of collaborations or potential collaborations with any other entities.

18/10/2021

Join the next meeting of the Club of Biotechnology and Life Sciences!

In the special edition on November 2 at 18:00 for the first time in Bulgaria will be presented the MBA training program of the Biotechnology Business Institute (BBI) Cambridge.

Meet with leading lecturers from Cambridge and Barcelona, who will introduce you to the training and accreditation opportunities.

Venrize Ltd. Academy is an exclusive partner with the world's leading universities in the field of biotechnology and medicine. The company provides students and professionals with access to the educational programs of some of the world's most famous universities, such as Cambridge, Oxford and Barcelona.

When: 2 November 2021 at 6:00 p.m. EET

Organizer: Health & Life Sciences Cluster Bulgaria, Sofia Tech Park, Venrize Academy

With the participation of leading lecturers and managers of the Biotechnology Business Institute (BBI) Cambridge BBI Business School (bbibarcelona.com)

The event will be broadcast live on:

Broadcast live on Facebook
25/10/2021

Venrize Academy & BBI go Southeast

World‘s first international eMBA in life sciences and biotechnology turns to Europe‘s most vibrant region

SOFIA, October 25, 2021 Тhe life sciences industry represent one of the fast growing economic sectors worldwide. To ensure its steady blossoming, the industry depends on young, ambitious talents for shaping the future of pharmaceutics and biotechnology. To answering the upcoming chalanges connected with the rising need of a experienced and qualified specialist , Venrize Academy and BBI joined forces to offer the world-renowned eMBA across Southeast Europe (Bulgaria, Romania, Serbia, Montenegro, North Macedonia, Albania, Kosovo, Bosna, Slovenia, Croatia, Greece and Turkey). Directed at BSc, MSc, or PhD holders in the life sciences, the program prepares them for being the leading scientific executives of tomorrow. Participants get deeply acquainted with the ever-evolving health-care ecosystem and learn to cope within and beyond it. Equipped with a personal mentor and embedded in an inclusive environment, students cultivate highly developed skills in macroeconomics, business strategy, planning and financial management—to name just a few—during the one year program. The eMBA offers a unique opportunity to work with a strong community of scientists, entrepreneurs, business leaders, corporates and investors from the very beginning. The dense business network, among which you find corporation such as Pfizer, Novartis, and Boehringer Ingelheim, for instance, enables every student to work on a real world drug discovery and development projects, immerse in technology transfer, venture building and international business development.

The career impact section of the program is tailored to the individual needs and aspirations of each student. The aim is to support the students throughout their career development and to help them find professional opportunities via internships, placement and full time employment. According numbers, 94% of the participants find an internship or a new job opportunity within their eMBA year. The two campuses in Barcelona and Cambridge offer a truly international experience and prepare the graduates to navigate their projects through a diverse and pluralistic world.

Venrize Academy (www.venrize.academy) is an online education provider with the mission to bring the most innovative and impactful education program to students and professionals across Southeast Europe. It offers access to academy ecosystem which provides continuous learning and professional development, allows students to gain and further develop their expertise, to accelerate their career, to build innovative businesses, and to grow their network by expanding their global horizons.

The Biotechnology Business Institute (BBI) (www.bbibarcelona.com) is a global academic institution which providers exclusive programmes in biotechnology and life sciences. With a presence in two of the main innovation centers in Europe, Barcelona and Cambridge, their students can choose which campus will best meet their needs. The Barcelona Campus focuses on Drug Discovery, which is central to future career progression in pharmaceutical and biotechnology companies. The newer Cambridge Campus has a broader remit across the entire Life Science sector. At Cambridge, UK, students can realize their objective of establishing a global network of contacts in the broader spectrum of commercial opportunities in Life Sciences. The BBI network is formed by their alumni, the academic staff, lecturers, partner companies and the technology transfer offices who collaborate with BBI. Over the years, BBI has developed a community over 700 people globally in direct contact every year.

Download PDF